Search Results
Search for other papers by Louis de Mestier in
Google Scholar
PubMed
Search for other papers by Angela Lamarca in
Google Scholar
PubMed
Search for other papers by Jorge Hernando in
Google Scholar
PubMed
Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Search for other papers by Wouter Zandee in
Google Scholar
PubMed
Search for other papers by Teresa Alonso-Gordoa in
Google Scholar
PubMed
Search for other papers by Marine Perrier in
Google Scholar
PubMed
Search for other papers by Annemiek ME Walenkamp in
Google Scholar
PubMed
Search for other papers by Bipasha Chakrabarty in
Google Scholar
PubMed
Search for other papers by Stefania Landolfi in
Google Scholar
PubMed
Search for other papers by Marie-Louise F Van Velthuysen in
Google Scholar
PubMed
Search for other papers by Gursah Kats-Ugurlu in
Google Scholar
PubMed
Search for other papers by Alejandra Caminoa in
Google Scholar
PubMed
Search for other papers by Maxime Ronot in
Google Scholar
PubMed
Search for other papers by Prakash Manoharan in
Google Scholar
PubMed
Search for other papers by Alejandro Garcia-Alvarez in
Google Scholar
PubMed
Search for other papers by Tessa Brabander in
Google Scholar
PubMed
Search for other papers by María Isabel García Gómez-Muriel in
Google Scholar
PubMed
Search for other papers by Guillaume Cadiot in
Google Scholar
PubMed
Search for other papers by Anne Couvelard in
Google Scholar
PubMed
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Marianne E Pavel in
Google Scholar
PubMed
Search for other papers by Jérôme Cros in
Google Scholar
PubMed
Introduction The classification of neuroendocrine neoplasms (NENs) relies on differentiation (well-differentiated neuroendocrine tumors (NETs) or poorly-differentiated neuroendocrine carcinomas (NECs)) and the proliferation index, which is
Search for other papers by Julien Hadoux in
Google Scholar
PubMed
Search for other papers by Thomas Walter in
Google Scholar
PubMed
Search for other papers by Christina Kanaan in
Google Scholar
PubMed
Search for other papers by Ségolène Hescot in
Google Scholar
PubMed
Search for other papers by Vincent Hautefeuille in
Google Scholar
PubMed
Search for other papers by Marine Perrier in
Google Scholar
PubMed
Laboratoire GReD, Université Clermont Auvergne, Clermont-Ferrand, France
Search for other papers by Igor Tauveron in
Google Scholar
PubMed
Search for other papers by Sandrine Laboureau in
Google Scholar
PubMed
Search for other papers by Christine Do Cao in
Google Scholar
PubMed
Search for other papers by Caroline Petorin in
Google Scholar
PubMed
Search for other papers by Odile Blanchet in
Google Scholar
PubMed
Search for other papers by Matthieu Faron in
Google Scholar
PubMed
Search for other papers by Emmanuelle Leteurtre in
Google Scholar
PubMed
Search for other papers by Marie-Christine Rousselet in
Google Scholar
PubMed
Search for other papers by Juliette Joubert Zakeyh in
Google Scholar
PubMed
Search for other papers by Aude Marchal in
Google Scholar
PubMed
Search for other papers by Denis Chatelain in
Google Scholar
PubMed
Search for other papers by Clément Beaulaton in
Google Scholar
PubMed
Search for other papers by Valérie Hervieu in
Google Scholar
PubMed
Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France
Search for other papers by Michel Ducreux in
Google Scholar
PubMed
Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France
Search for other papers by Jean-Yves Scoazec in
Google Scholar
PubMed
Search for other papers by Eric Baudin in
Google Scholar
PubMed
Search for other papers by the Groupe d’Etude des Tumeurs Endocrines (GTE) in
Google Scholar
PubMed
Search for other papers by the ENDOCAN-RENATEN network in
Google Scholar
PubMed
Patients This was a multicentre retrospective study of seven tertiary centres of the French expert network for the management of neuroendocrine neoplasms ENDOCAN-RENATEN (approved by the French National Cancer Institute, INCa). Patients were diagnosed
Search for other papers by Igryl S Cordero-Hernandez in
Google Scholar
PubMed
Search for other papers by Alicia C Ross in
Google Scholar
PubMed
Search for other papers by Arvind Dasari in
Google Scholar
PubMed
Search for other papers by Daniel M Halperin in
Google Scholar
PubMed
Search for other papers by Beth Chasen in
Google Scholar
PubMed
Search for other papers by James C Yao in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NEN) are a heterogenous group of malignancies, most commonly arising from gastroenteropancreatic (GEP) sites, with increasing incidence and prevalence worldwide ( Dasari et al. 2017 , Das & Dasari 2021
Division of Cancer Sciences, University of Manchester, Manchester, UK
Search for other papers by Mairéad G McNamara in
Google Scholar
PubMed
Université Paris Sud, Faculté de Médecine de Bicêtre, Le Kremlin-Bicêtre, France
Search for other papers by Jean-Yves Scoazec in
Google Scholar
PubMed
Search for other papers by Thomas Walter in
Google Scholar
PubMed
al . 2016 , McNamara et al . 2019 ). There has been recent progress in the pathological diagnosis of high grade neuroendocrine neoplasms (NENs) ( Lloyd et al . 2017 , Rindi et al . 2018 a ) and in the description of their molecular and immune
Université de Paris, Centre de Recherche sur l’Inflammation, INSERM, Paris, France
Search for other papers by Ophélie De Rycke in
Google Scholar
PubMed
Search for other papers by Thomas Walter in
Google Scholar
PubMed
Search for other papers by Marine Perrier in
Google Scholar
PubMed
Search for other papers by Olivia Hentic in
Google Scholar
PubMed
Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Search for other papers by Romain Coriat in
Google Scholar
PubMed
Search for other papers by Guillaume Cadiot in
Google Scholar
PubMed
Department of Pathology, ENETS Centre of Excellence, Bichat/Beaujon University Hospital, Paris/Clichy, France
Search for other papers by Anne Couvelard in
Google Scholar
PubMed
Université de Paris, Centre de Recherche sur l’Inflammation, INSERM, Paris, France
Search for other papers by Philippe Ruszniewski in
Google Scholar
PubMed
Department of Pathology, ENETS Centre of Excellence, Bichat/Beaujon University Hospital, Paris/Clichy, France
Search for other papers by Jérôme Cros in
Google Scholar
PubMed
Université de Paris, Centre de Recherche sur l’Inflammation, INSERM, Paris, France
Search for other papers by Louis de Mestier in
Google Scholar
PubMed
, 2018 Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study . Endocrine 60 490 – 498 . ( https://doi.org/10.1007/s12020
Search for other papers by S Felder in
Google Scholar
PubMed
Search for other papers by H Jann in
Google Scholar
PubMed
Search for other papers by R Arsenic in
Google Scholar
PubMed
Search for other papers by T Denecke in
Google Scholar
PubMed
Klinik für Nuklearmedizin, Universitätklinikum Ulm, Ulm, Germany
Search for other papers by V Prasad in
Google Scholar
PubMed
Search for other papers by B Knappe-Drzikova in
Google Scholar
PubMed
Innere Medizin und Gastroenterologie, Asklepios Klinik St. Georg, Asklepios Medical School, Hamburg, Germany
Search for other papers by S Maasberg in
Google Scholar
PubMed
Search for other papers by B Wiedenmann in
Google Scholar
PubMed
Medizinische Klinik 1, Gastroenterologie, Pneumologie und Endokrinologie, Universitätsklinikum der Friedrich-Alexander Universität Erlangen, Erlangen, Germany
Search for other papers by M Pavel in
Google Scholar
PubMed
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Uinversitätsklinikum Münster, Münster, Germany
Search for other papers by A Pascher in
Google Scholar
PubMed
Innere Medizin und Gastroenterologie, Asklepios Klinik St. Georg, Asklepios Medical School, Hamburg, Germany
Search for other papers by U F Pape in
Google Scholar
PubMed
G Fazio N , et al . 2016 Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study . Endocrine 51 . ( https://doi.org/10.1007/s12020-015-0584-z
Department of Endocrine Oncology, Department of Medical Sciences, University Hospital, Entrance 78, SE-751 85 Uppsala, Sweden
Search for other papers by Kjell Oberg in
Google Scholar
PubMed
classification and the pathology of gastro-entero-pancreatic neuroendocrine neoplasms is discussed by Prof. Günter Klöppel ( Klöppel 2011 ). A number of biomarkers has been developed during the last decades based on development of the immunoassays for various gut
Search for other papers by Frank Weber in
Google Scholar
PubMed
Search for other papers by Lois M Mulligan in
Google Scholar
PubMed
-endocrine manifestations (i.e., adrenocortical neoplasm, thymic and bronchial neuroendocrine neoplasms, breast and soft tissue tumors) beyond the parathyroid adenoma, gastrinoma and prolactinoma described originally, and also to understand the genetic, epigenetic and post
Search for other papers by Anela Blažević in
Google Scholar
PubMed
Search for other papers by Anand M Iyer in
Google Scholar
PubMed
Search for other papers by Marie-Louise F van Velthuysen in
Google Scholar
PubMed
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Search for other papers by Gaston J H Franssen in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Marina Zajec in
Google Scholar
PubMed
Search for other papers by Theo M Luider in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
small bowel neuroendocrine neoplasms . Endocrine 67 718 – 726 . ( https://doi.org/10.1007/s12020-019-02107-4 ) Laskaratos FM Walker M Wilkins D Tuck A Ramakrishnan S Phillips E Gertner J Megapanou M Papantoniou D Shah R , 2018
Search for other papers by Massimo Milione in
Google Scholar
PubMed
Search for other papers by Patrick Maisonneuve in
Google Scholar
PubMed
Search for other papers by Alessio Pellegrinelli in
Google Scholar
PubMed
Search for other papers by Federica Grillo in
Google Scholar
PubMed
Search for other papers by Luca Albarello in
Google Scholar
PubMed
Search for other papers by Paola Spaggiari in
Google Scholar
PubMed
Search for other papers by Alessandro Vanoli in
Google Scholar
PubMed
Search for other papers by Giovanna Tagliabue in
Google Scholar
PubMed
Search for other papers by Eleonora Pisa in
Google Scholar
PubMed
Search for other papers by Luca Messerini in
Google Scholar
PubMed
Clinical Research Lab (CRAB), Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Search for other papers by Giovanni Centonze in
Google Scholar
PubMed
Search for other papers by Frediano Inzani in
Google Scholar
PubMed
Search for other papers by Aldo Scarpa in
Google Scholar
PubMed
Search for other papers by Mauro Papotti in
Google Scholar
PubMed
Search for other papers by Marco Volante in
Google Scholar
PubMed
Search for other papers by Fausto Sessa in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
University of Milan, School of Medicine, Milan, Italy
Search for other papers by Giancarlo Pruneri in
Google Scholar
PubMed
Search for other papers by Guido Rindi in
Google Scholar
PubMed
Search for other papers by Enrico Solcia in
Google Scholar
PubMed
Search for other papers by Stefano La Rosa in
Google Scholar
PubMed
Search for other papers by Carlo Capella in
Google Scholar
PubMed
widely shown to be an important diagnostic tool for neuroendocrine neoplasms, this study, has added new and interesting findings with regards to the importance of proliferation in MANECs as well. Indeed, as previously reported for pure NECs ( Sorbye et